De La Monte; Suzanne

Patent Applications and Registrations

Patent applications and USPTO patent grants for De La Monte; Suzanne.The latest application filed is for "inhibitors of beta-hydroxylase for treatment of cancer".

Company Profile

1.12.9

De La Monte; Suzanne - East Greenwich RI
De La Monte; Suzanne - Providence RI
de la Monte, Suzanne - Greenwich RI
de la Monte; Suzanne - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors Of Beta-hydroxylase For Treatment Of Cancer App 20200361925 - Wands; Jack R. ; et al.	2020-11-19
Inhibitors of .beta.-hydroxylase for treatment of cancer Grant 10,710,995 - Wands , et al.	2020-07-14
Inhibitors Of Beta-hydroxylase For Treatment Of Cancer App 20180237427 - Wands; Jack R. ; et al.	2018-08-23
Inhibitors of beta-hydroxylase for treatment of cancer Grant 9,771,356 - Wands , et al. September 26, 2	2017-09-26
Inhibitors of Beta-Hydroxylase for Treatment of Cancer App 20150210677 - Wands; Jack R. ; et al.	2015-07-30
Method for treating or preventing Alzheimer's disease Grant 7,300,927 - Esmond , et al. November 27, 2	2007-11-27
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease Grant 7,291,454 - de la Monte , et al. November 6, 2	2007-11-06
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's Disease Grant 7,226,730 - De La Monte , et al. June 5, 2	2007-06-05
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease Grant 7,138,380 - De La Monte , et al. November 21, 2	2006-11-21
Treatment of glioblastoma with thymosin-alpha 1 App 20060166870 - Wands; Jack R. ; et al.	2006-07-27
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease Grant 7,045,616 - de la Monte , et al. May 16, 2	2006-05-16
Method for treating or preventing Alzheimer's disease App 20050043242 - Esmond, Robert W. ; et al.	2005-02-24
Method for treating or preventing Alzheimer's disease App 20040060077 - Esmond, Robert W. ; et al.	2004-03-25
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease App 20030033621 - De La Monte, Suzanne ; et al.	2003-02-13
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease App 20020129391 - De La Monte, Suzanne ; et al.	2002-09-12
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease App 20020104108 - De La Monte, Suzanne ; et al.	2002-08-01
Method of detecting neurological disease or dysfunction Grant 6,071,705 - Wands , et al. June 6, 2	2000-06-06
Neural thread protein gene expression and detection of alzheimer's disease Grant 5,948,634 - de la Monte , et al. September 7, 1	1999-09-07
Neural thread protein gene expression and detection of Alzheimer's disease Grant 5,948,888 - de la Monte , et al. September 7, 1	1999-09-07
Neural thread protein gene expression and detection of Alzheimer's disease Grant 5,830,670 - de la Monte , et al. November 3, 1	1998-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.